Lymphocytic Variant Hypereosinophilic Syndromes

Immunology and Allergy Clinics of North America

Volumn 27, Issue 3, 2007, Pages 389-413

  Roufosse, Florence ^a,b   Cogan, Elie ^a   Goldman, Michel ^b  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ALPHA INTERFERON; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOXORUBICIN; HYDROXYUREA; IMATINIB; IMMUNOMODULATING AGENT; INTERFERON; INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY; MONOCLONAL ANTIBODY; NITROGEN; PREDNISOLONE; PREDNISONE; PROCARBAZINE; PROTEIN TYROSINE KINASE INHIBITOR; VINCRISTINE; VINDESINE;

ALLERGIC DISEASE; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; FOLLOW UP; HUMAN; HYPEREOSINOPHILIC SYNDROME; LYMPHOCYTE; PARASITOSIS; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PUVA; REVIEW; T LYMPHOCYTE;

ANTIGENS, CD; CYTOKINES; HUMANS; HYPEREOSINOPHILIC SYNDROME; MYELOPROLIFERATIVE DISORDERS; T-LYMPHOCYTE SUBSETS;

EID: 34548490762     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2007.07.002     Document Type: Review

References (68)

1. Fletcher S., and Bain B. Diagnosis and treatment of hypereosinophilic syndromes. Curr Opin Hematol 14 1 (2007) 37-42
2. Mosmann T.R., Cherwinski H., Bond M.W., et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136 7 (1986) 2348-2357
3. Campbell H.D., Tucker W.Q., Hort Y., et al. Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5). Proc Natl Acad Sci U S A 84 19 (1987) 6629-6633
4. Romagnani S. Th1 and Th2 in human diseases. Clin Immunol Immunopathol 80 3 Pt 1 (1996) 225-235
5. Fauci A.S., Harley J.B., Roberts W.C., et al. NIH conference. The idiopathic hypereosinophilic syndrome: clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 97 1 (1982) 78-92
6. Raghavachar A., Fleischer S., Frickhofen N., et al. T lymphocyte control of human eosinophilic granulopoiesis: clonal analysis in an idiopathic hypereosinophilic syndrome. J Immunol 139 11 (1987) 3753-3758
7. Schrezenmeier H., Thome S.D., Tewald F., et al. Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome. Exp Hematol 21 2 (1993) 358-365
8. Cogan E., Schandene L., Crusiaux A., et al. Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 330 8 (1994) 535-538
9. Chusid M.J., Dale D.C., West B.C., et al. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54 1 (1975) 1-27
10. Simon H.U., Plotz S.G., Dummer R., et al. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 341 15 (1999) 1112-1120
11. Roufosse F., Schandene L., Sibille C., et al. Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome. Br J Haematol 109 3 (2000) 540-548
12. Bank I., Amariglio N., Reshef A., et al. The hypereosinophilic syndrome associated with CD4+CD3- helper type 2 (Th2) lymphocytes. Leuk Lymphoma 42 1-2 (2001) 123-133
13. Willard-Gallo K.E., Badran B.M., Ravoet M., et al. Defective CD3gamma gene transcription is associated with NFATc2 overexpression in the lymphocytic variant of hypereosinophilic syndrome. Exp Hematol 33 10 (2005) 1147-1159
14. Edelman J., and Meyerson H.J. Diminished CD3 expression is useful for detecting and enumerating Sézary cells. Am J Clin Pathol 114 3 (2000) 467-477
15. Yokote T., Akioka T., Oka S., et al. Flow cytometric immunophenotyping of adult T-cell leukemia/lymphoma using CD3 gating. Am J Clin Pathol 124 2 (2005) 199-204
16. Serke S., van Lessen A., Hummel M., et al. Circulating CD4+ T lymphocytes with intracellular but no surface CD3 antigen in five of seven patients consecutively diagnosed with angioimmunoblastic T-cell lymphoma. Cytometry 42 3 (2000) 180-187
17. Schandene L., Roufosse F., de Lavareille A., et al. Interferon alpha prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia. Blood 96 13 (2000) 4285-4292
18. Roufosse F., Schandene L., Sibille C., et al. T-cell receptor-independent activation of clonal Th2 cells associated with chronic hypereosinophilia. Blood 94 3 (1999) 994-1002
19. O'Shea J.J., Jaffe E.S., Lane H.C., et al. Peripheral T cell lymphoma presenting as hypereosinophilia with vasculitis: clinical, pathologic, and immunologic features. Am J Med 82 3 (1987) 539-545
20. Brugnoni D., Airo P., Rossi G., et al. A case of hypereosinophilic syndrome is associated with the expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin-5. Blood 87 4 (1996) 1416-1422
21. Roumier A.S., Grardel N., Lai J.L., et al. Hypereosinophilia with abnormal T cells, trisomy 7 and elevated TARC serum level. Haematologica 88 7 (2003) ECR24
22. Bank I., Reshef A., Beniaminov M., et al. Role of gamma/delta T cells in a patient with CD4+CD3- lymphocytosis, hypereosinophilia, and high levels of IgE. J Allergy Clin Immunol 102 4 Pt 1 (1998) 621-630
23. Sugimoto K., Tamayose K., Sasaki M., et al. More than 13 years of hypereosinophila associated with clonal CD3-CD4+ lymphocytosis of TH2/TH0 type. Int J Hematol 75 3 (2002) 281-284
24. Costello R., Cerdan C., Pavon C., et al. The CD2 and CD28 adhesion molecules induce long-term autocrine proliferation of CD4+ T cells. Eur J Immunol 23 3 (1993) 608-613
25. Cerdan C., Martin Y., Courcoul M., et al. Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation. J Immunol 149 7 (1992) 2255-2261
26. Cerdan C., Martin Y., Courcoul M., et al. CD28 costimulation up-regulates long-term IL-2R beta expression in human T cells through combined transcriptional and post-transcriptional regulation. J Immunol 154 3 (1995) 1007-1013
27. Willard-Gallo K.E., Van de Keere F., and Kettmann R. A specific defect in CD3 gamma-chain gene transcription results in loss of T-cell receptor/CD3 expression late after human immunodeficiency virus infection of a CD4+ T-cell line. Proc Natl Acad Sci U S A 87 17 (1990) 6713-6717
28. -) alphabeta(+) T cells with chromosome 16 abnormalities. Br J Haematol 92 (1996) 315-317
29. Simon H.U., Yousefi S., Dommann-Scherrer C.C., et al. Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med 183 3 (1996) 1071-1082
30. Vaklavas C., Tefferi A., Butterfield J., et al. Idiopathic eosinophilia with an occult T-cell clone: prevalence and clinical course. Leuk Res 31 (2007) 691-694
31. Davis A.L., McKenzie J.L., and Hart D.N. HLA-DR-positive leucocyte subpopulations in human skin include dendritic cells, macrophages, and CD7-negative T cells. Immunology 65 4 (1988) 573-581
32. Groh V., Fabbi M., Hochstenbach F., et al. Double-negative (CD4-CD8-) lymphocytes bearing T-cell receptor alpha and beta chains in normal human skin. Proc Natl Acad Sci U S A 86 13 (1989) 5059-5063
33. Reinhold U., Abken H., Kukel S., et al. CD7- T cells represent a subset of normal human blood lymphocytes. J Immunol 150 5 (1993) 2081-2089
34. Autran B., Legac E., Blanc C., et al. A Th0/Th2-like function of CD4+CD7- T helper cells from normal donors and HIV-infected patients. J Immunol 154 3 (1995) 1408-1417
35. Hodak E., David M., Maron L., et al. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides. J Am Acad Dermatol 55 2 (2006) 276-284
36. Wood G.S., Hong S.R., Sasaki D.T., et al. Leu-8/CD7 antigen expression by CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values. J Am Acad Dermatol 22 4 (1990) 602-607
37. Rappl G., Muche J.M., Abken H., et al. CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome. J Am Acad Dermatol 44 3 (2001) 456-461
38. Zenone T., Felman P., Malcus C., et al. Indolent course of a patient with hypereosinophilic syndrome associated with clonal T-cell proliferation. Am J Med 107 5 (1999) 509-511
39. Morgan S.J., Prince H.M., Westerman D.A., et al. Clonal T-helper lymphocytes and elevated IL-5 levels in episodic angioedema and eosinophilia (Gleich's syndrome). Leuk Lymphoma 44 9 (2003) 1623-1625
40. Pitini V., Teti D., Arrigo C., et al. Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report. Br J Haematol 127 5 (2004) 477
41. Bagot M., Bodemer C., Wechsler J., et al. [Non epidermotropic T lymphoma preceded for several years by hypereosinophilic syndrome]. Ann Dermatol Venereol 117 11 (1990) 883-885 [in French]
42. de Lavareille A., Roufosse F., Schmid-Grendelmeier P., et al. High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome. J Allergy Clin Immunol 110 3 (2002) 476-479
43. de Lavareille A., Roufosse F., Schandene L., et al. Clonal Th2 cells associated with chronic hypereosinophilia: TARC-induced CCR4 down-regulation in vivo. Eur J Immunol 31 4 (2001) 1037-1046
44. Sekiya T., Miyamasu M., Imanishi M., et al. Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells. J Immunol 165 4 (2000) 2205-2213
45. Xiao T., Fujita H., Saeki H., et al. Thymus and activation-regulated chemokine (TARC/CCL17) produced by mouse epidermal Langerhans cells is upregulated by TNF-alpha and IL-4 and downregulated by IFN-gamma. Cytokine 23 4-5 (2003) 126-132
46. Kakinuma T., Nakamura K., Wakugawa M., et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 107 3 (2001) 535-541
47. Roufosse F., Cogan E., and Goldman M. The hypereosinophilic syndrome revisited. Annu Rev Med 54 (2003) 169-184
48. Ravoet M., Sibille C., Roufosse F., et al. 6q- is an early and persistent chromosomal aberration in CD3-CD4+ T-cell clones associated with the lymphocytic variant of hypereosinophilic syndrome. Haematologica 90 6 (2005) 753-765
49. Thangavelu M., Finn W.G., Yelavarthi K.K., et al. Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome. Blood 89 9 (1997) 3371-3377
50. Simon H.U. Eosinophil apoptosis: pathophysiologic and therapeutic implications. Allergy 55 10 (2000) 910-915
51. Batuman O.A., Ferrero A.P., Diaz A., et al. Glucocorticoid-mediated inhibition of interleukin-2 receptor alpha and -beta subunit expression by human T cells. Immunopharmacology 27 1 (1994) 43-55
52. Braun C.M., Huang S.K., Bashian G.G., et al. Corticosteroid modulation of human, antigen-specific Th1 and Th2 responses. J Allergy Clin Immunol 100 3 (1997) 400-407
53. Nakajima H., Nakao A., Watanabe Y., et al. IFN-alpha inhibits antigen-induced eosinophil and CD4+ T cell recruitment into tissue. J Immunol 153 3 (1994) 1264-1270
54. Maggi E., Parronchi P., Manetti R., et al. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 148 7 (1992) 2142-2147
55. Schandene L., Del Prete G.F., Cogan E., et al. Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells. J Clin Invest 97 2 (1996) 309-315
56. Broxmeyer H.E., Lu L., Platzer E., et al. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol 131 3 (1983) 1300-1305
57. Klion A.D., Bochner B.S., Gleich G.J., et al. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol 117 6 (2006) 1292-1302
58. Cools J., DeAngelo D.J., Gotlib J., et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348 13 (2003) 1201-1214
59. Pardanani A., Reeder T., Porrata L.F., et al. Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders. Blood 101 9 (2003) 3391-3397
60. Lenihan D.J., Alencar A.J., Yang D., et al. Cardiac toxicity of alemtuzumab in patients with mycosis fungoides/Sézary syndrome. Blood 104 3 (2004) 655-658
61. Garrett J.K., Jameson S.C., Thomson B., et al. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 113 1 (2004) 115-119
62. Plotz S.G., Simon H.U., Darsow U., et al. Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis. N Engl J Med 349 24 (2003) 2334-2339
63. Klion A.D., Law M.A., Noel P., et al. Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome. Blood 103 8 (2004) 2939-2941
64. Prinz B., Michelsen S., Pfeiffer C., et al. Long-term application of extracorporeal photochemotherapy in severe atopic dermatitis. J Am Acad Dermatol 40 4 (1999) 577-582
65. Crovetti G., Carabelli A., Berti E., et al. Photopheresis in cutaneous T-cell lymphoma: five-year experience. Int J Artif Organs 23 1 (2000) 55-62
66. Aubin F., Salard D., Poutier F., et al. La photochimiothérapie extracorporelle. Medicine Science 15 (1999) 983-989
67. Adkins J.C., Peters D.H., and Markham A. Fludarabine: an update of its pharmacology and use in the treatment of haematological malignancies. Drugs 53 6 (1997) 1005-1037
68. Quaglino P., Fierro M.T., Rossotto G.L., et al. Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy. Br J Dermatol 150 2 (2004) 327-336